Enable Injections

Thank you to everyone who visited our booth at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago! Our team enjoyed meeting so many of you and demonstrating the innovative enFuse® On-Body Injector.

To learn more, please visit: https://enableinjections.com/contact-us/

We are excited to announce CE Certification of the enFuse® on-body injector and syringe transfer system for use in combination with Aspaveli®, commercialized as ASPAVELI® enFuse® and distributed by Sobi - Swedish Orphan Biovitrum AB (publ)("Sobi") across the European Union.

This certification marks another regulatory milestone for our technology and supports our ongoing global expansion efforts to bring the enFuse system to more patients internationally.

Read more here: https://bit.ly/3PhvbK3

We’re excited to be at ONS Annual Congress next week in San Antonio, Texas! Visit us at Booth #504 for enFuse® demonstrations.

Also, be sure to join Haydon DuMond for his presentation, “United Kingdom Nurse and Pharmacist Preferences for On-Body Injector Technology Versus Traditional Manual Syringes in Large-Volume Subcutaneous Drug Delivery” on Thursday, May 14, 2026, 2:00–2:50 PM
Tower View Registration, Poster Pavilion, Poster Monitor 14.

If you plan to attend ONS, we look forward to connecting. Feel free to reach out to Haydon directly or visit: https://enableinjections.com/contact-us/

See you there!